5521 - 5530 of 9039 Results
Title
Year
-
OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 139
-
OPENTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 8
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 147
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7
-
OPENTitle: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 1Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3Best OA location URL: http://doi.org/10.1016/S1474-4422(16)30328-3Citation Count: 435
-
OPENTitle: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning studyJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 1Issue #: 5Start Page: e222End Page: e231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0Best OA location URL: http://www.thelancet.com/article/S2589750019301050/pdfCitation Count: 119
-
OPENTitle: α-synuclein seed amplification in Parkinson‘s diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 984End Page: 985Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00374-5Best OA location URL: http://www.thelancet.com/article/S1474442223003745/pdfCitation Count: 3
- α-synuclein seed amplification in Parkinson‘s disease2023RESTRICTEDTitle: α-synuclein seed amplification in Parkinson‘s diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 985Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00373-3Citation Count: 3
-
OPENTitle: Sex Differences in Cognitive Changes in De Novo Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 26Issue #: 2Start Page: 241End Page: 249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617719001085Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282562Citation Count: 16
-
OPENTitle: Mental health disparities and the role of perceived discrimination among Latinx individuals living with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105867End Page: 105867Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105867Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105867Citation Count: 6